Jci_page_head_homepage_01 Jci_page_head_homepage_02
This page
  • Citations to this article
Dendritic cells: at the clinical crossroads
James J. Mulé
Published in Volume 105, Issue 6
J Clin Invest. 2000; 105(6):707 doi:10.1172/JCI9591
Full text | PDF
Citation information
  • Citation in:
  • Citations:
  • 2010
  • 1
  • 2009
  • 2
  • 2003
  • 1
  • 2002
  • 2
  • 2001
  • 1
  • Total
  • 5
 
Title and authors Publication Year .
Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity
Norimasa Matsushita, Hiroshi Komine, Annabelle Grolleau-Julius, Shari Pilon-Thomas, James J. Mulé		 Cancer Immunol Immunother 2010 .
Specifically activated dendritic cells—Cell-based vaccine against lymphosarcoma exhibiting multiple drug resistance phenotype
N. L. Mironova, E. E. Panzinskyi, N. A. Popova, V. P. Nikolin, M. A. Zenkova, V. V. Vlasov		 Dokl Biochem Biophys 2009 .
Dendritic Cell-Based Vaccines for Pancreatic Cancer and Melanoma
James J. Mulé		 Annals of the New York Academy of Sciences 2009 .
Enhancing dendritic cell-based vaccines by gene modification
Alicia Terando, James J. Mulé		 Blood Cells Molecules and Disease 2003 .
M-Vax: an autologous, hapten-modified vaccine for human cancer
David Berd		 ebot 2002 .
Immunological weapons against acute myeloid leukaemia
Joanna Galea-Lauri		 Immunology 2002 .
STRATEGIES FOR DESIGNING AND OPTIMIZING NEW GENERATION VACCINES
Jay A. Berzofsky, Jeffrey D. Ahlers, Igor M. Belyakov		 Nature Review Immunology 2001 .
Copyright © 2011 American Society for Clinical Investigation.
The JCI is the publication of the ASCI, an honor society of physician-scientists.
Copying, redistribution, and other usage policies